ClinicalTrials.govpublic full text
The Prognostic Impact of HER2 Expression in Non-Metastatic HER2-Positive Breast Cancer Treated With Dual HER2-Targeted Therapy
breast cancer, her2/cep17 ratio, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 874621
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.